1,027 material Form 8-K filings that 835 companies we cover made with the SEC in February 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Post Holdings reported first-quarter fiscal 2025 results for the period ended December 31, 2024, with net sales of $1,974.7 million, up 0.4%, and net earnings of $113.3 million, up 28.6%. The company raised its fiscal 2025 Adjusted EBITDA outlook to $1,420-$1,460 million from $1,410-$1,460 million and approved a new $500 million share repurchase authorization effective February 10, 2025, which replaces the existing program.
Net sales were $1,974.7 million, up 0.4% from $1,965.9 million; diluted EPS was $1.78 versus $1.35 a year earlier
Adjusted diluted EPS was $1.73 versus $1.69; Adjusted net earnings were $111.9 million versus $113.7 million
Fiscal 2025 Adjusted EBITDA outlook raised to $1,420-$1,460 million from $1,410-$1,460 million
New $500 million buyback approved February 4, 2025; $200.2 million remained under the existing authorization as of February 6, 2025, which will be cancelled February 9, 2025
Globus Medical agreed to acquire Nevro Corp. in an all-cash transaction valued at approximately $250 million in total equity value, subject to Nevro shareholder approval, regulatory clearance and other closing conditions. Globus Medical said that after the deal closes it expects higher 2025 net sales but lower non-GAAP earnings per share than its stand-alone guidance.
Nevro shareholders will receive $5.85 per share in cash, a 17% premium to Nevro's February 5, 2025 closing price.
Globus Medical expects the deal to close late in the second quarter of 2025 and anticipates the Nevro acquisition to be accretive to earnings in the second year of operation.
Post-deal 2025 guidance: net sales of $2.80 billion to $2.90 billion (versus stand-alone $2.66 billion to $2.69 billion) and non-GAAP EPS of $3.10 to $3.40 (versus stand-alone $3.40 to $3.50).
Termination fees: Nevro would pay $15 million or $10 million in certain circumstances, including a failed stockholder vote; Globus Medical would pay $15 million in certain circumstances.
Principal Financial Group reported fourth-quarter and full-year 2024 results, with GAAP net income of $905.4 million in the quarter versus a $871.7 million loss a year earlier. It also raised its first-quarter 2025 dividend to $0.75 per share and approved a new $1.5 billion share repurchase authorization, while its 2025 outlook is consistent with long-term targets of 9-12% non-GAAP operating EPS growth.
4Q24 GAAP net income attributable to PFG was $905.4 million, or $3.92 per diluted share, compared with a loss of $871.7 million, or $3.66 per share, in 4Q23
4Q24 non-GAAP operating earnings per diluted share were $1.94, up 6% from $1.83; full-year 2024 was $7.65 excluding significant variances, up 11%
Quarterly dividend raised to $0.75 per share, payable March 28, 2025, to shareholders of record as of March 12, 2025
Board approved a new $1.5 billion share repurchase authorization; about $0.8 billion remained under the prior authorization at December 31, 2024
On February 4, 2025, Sprinklr committed to a reduction in force affecting about 15% of its global workforce as of January 31, 2025, which it says will realign employee costs with the current business and free up capital for investments in go-to-market and R&D resources. The company estimates about $25 million in non-recurring charges, mostly in the first and second quarters of fiscal 2026. It also expects its results for the quarter and fiscal year ended January 31, 2025 to be in line with or above its December 4, 2024 guidance, with formal guidance to come at its March 2025 earnings call.
Reduction in force of about 15% of global workforce, committed February 4, 2025
Estimated non-recurring charges of about $25 million, mostly in Q1 and Q2 of fiscal 2026
Preliminary quarter and fiscal year ended January 31, 2025 results expected in line with or above December 4, 2024 guidance
Formal guidance for quarter ending April 30, 2025 and fiscal 2026 to be provided at March 2025 earnings call
Encompass Health reported fourth-quarter 2024 net operating revenue of $1,405.0 million, up 12.7%, and diluted earnings per share from continuing operations of $1.18, up from $0.94 a year earlier. The company also issued 2025 guidance for net operating revenue of $5,800 million to $5,900 million, Adjusted EBITDA of $1,160 million to $1,200 million, and adjusted earnings per share of $4.67 to $4.96.
Q4 2024 net operating revenue was $1,405.0 million, up from $1,246.8 million; diluted EPS from continuing operations was $1.18 versus $0.94
Q4 2024 Adjusted EBITDA was $289.6 million, up 13.6%; adjusted EPS was $1.17 versus $0.95
2025 guidance: net operating revenue $5,800 million to $5,900 million; Adjusted EBITDA $1,160 million to $1,200 million; adjusted EPS $4.67 to $4.96
Management will discuss results on an earnings call at 10:00 a.m. Eastern Time on February 7, 2025
Lumentum reported fiscal second quarter 2025 net revenue of $402.2 million, up 19.4% from the prior quarter and 9.7% from a year earlier, with GAAP net loss narrowing to $60.9 million, or $0.88 per diluted share. It guided fiscal third quarter net revenue to $410 million to $425 million and non-GAAP diluted EPS to $0.47 to $0.53, and said CEO Alan Lowe will transition to Michael Hurlston.
Q2 net revenue $402.2 million vs. $336.9 million in Q1 and $366.8 million in Q2 2024
GAAP net loss $60.9 million ($0.88 per diluted share) vs. $82.4 million in Q1 and $99.1 million in Q2 2024
Q3 fiscal 2025 outlook: net revenue $410 million to $425 million; non-GAAP diluted EPS $0.47 to $0.53
Cash, cash equivalents and short-term investments were $896.7 million, down $19.4 million from Q1
ESCO reported fiscal first-quarter 2025 sales of $247.0 million, up 13.2%, and GAAP EPS of $0.91 versus $0.59 a year earlier. The company raised its full-year fiscal 2025 adjusted EPS guidance to $5.55 to $5.75 from $5.30 to $5.50, though it now excludes acquisition-related amortization from adjusted EPS. The filing also covered the annual meeting, where directors and executive pay were approved, and a board reduction from nine to eight directors.
Q1 fiscal 2025 sales were $247.0 million, up from $218.3 million; GAAP EPS was $0.91 versus $0.59.
Adjusted EPS excluding acquisition-related amortization was $1.07, up 41% from $0.76 a year earlier.
Full-year fiscal 2025 adjusted EPS guidance raised by $0.25 to $5.55 to $5.75; Q2 adjusted EPS guidance is $1.20 to $1.30.
Pending $550 million SM&P acquisition; US closing conditions met, UK review in final stages. Board size cut to eight after Leon J. Olivier retired.
Genpact reported full-year 2024 net revenues of $4.77 billion, up 6.5%, and adjusted diluted EPS of $3.28, up 10%. GAAP diluted EPS fell 16% to $2.85 and net income fell 19% to $514 million, with the 2023 comparison including a $170 million non-recurring tax benefit. The company also raised its quarterly dividend 11% to $0.17 and added $500 million to its share repurchase authorization, and it guided to 2025 adjusted diluted EPS of $3.52 to $3.59.
Full-year 2024 net revenues were $4.77 billion, up 6.5%; fourth-quarter net revenues were $1.25 billion, up 8.9%
Diluted EPS was $2.85, down 16%; adjusted diluted EPS was $3.28, up 10%
2025 outlook: net revenues of $5.029 billion to $5.125 billion and adjusted diluted EPS of $3.52 to $3.59
Quarterly dividend raised to $0.17 per share (11% increase), payable March 26, 2025; repurchase authorization increased by $500 million
QuinStreet reported record fiscal second quarter 2025 revenue of $282.6 million for the quarter ended December 31, 2024, up 130% year-over-year, and posted a GAAP net loss of $1.5 million, or $0.03 per diluted share. The company raised its full fiscal 2025 outlook, now expecting revenue of $1.065 billion to $1.105 billion and Adjusted EBITDA of $80 million to $85 million.
Q2 revenue was $282.6 million, up 130% year-over-year, with Auto Insurance revenue up 615% and non-insurance revenue up 15%.
GAAP net loss narrowed to $1.5 million, or $0.03 per diluted share, from a net loss of $11.6 million a year earlier; adjusted net income was $11.9 million, or $0.20 per diluted share.
Adjusted EBITDA was $19.4 million for the quarter, compared with $417 thousand a year earlier.
For fiscal Q3, the company expects revenue of $265 million to $275 million and Adjusted EBITDA of $19.5 million to $20.0 million.
NMI Holdings reported fourth-quarter 2024 net income of $86.2 million, or $1.07 per diluted share, up from $83.4 million and $1.01 a year earlier but down from $92.8 million and $1.15 in the third quarter. Full-year 2024 net income rose to $360.1 million, or $4.43 per diluted share, from $322.1 million, or $3.84, in 2023, and the board authorized an additional $250 million share repurchase through December 31, 2027.
Q4 2024 net income $86.2 million, $1.07 per diluted share, vs. $83.4 million, $1.01 in Q4 2023 and $92.8 million, $1.15 in Q3 2024
Full-year 2024 net income $360.1 million, $4.43 per diluted share, vs. $322.1 million, $3.84 in 2023; adjusted diluted EPS $4.50
Q4 2024 loss ratio 12.0%, up from 6.2% a year earlier and 7.2% in Q3 2024; total revenue $166.5 million
Board authorized an additional $250 million share repurchase plan effective through December 31, 2027
Fortinet reported fourth-quarter 2024 revenue of $1.66 billion, up 17.3% from a year earlier, and GAAP diluted EPS of $0.68 versus $0.40. It also issued 2025 revenue guidance of $6.650 billion to $6.850 billion, compared with full-year 2024 revenue of $5.96 billion. Chief Financial Officer Keith Jensen plans to retire on May 15, 2025, and Chief Accounting Officer Christiane Ohlgart is expected to succeed him, which shareholders may watch during the transition.
Q4 2024 revenue was $1.66 billion, up 17.3% from $1.42 billion; GAAP net income was $526.2 million.
GAAP diluted EPS was $0.68 for Q4 2024, compared with $0.40 a year earlier.
2025 guidance: revenue of $6.650 billion to $6.850 billion; Q1 2025 revenue of $1.500 billion to $1.560 billion.
Keith Jensen, 66, will retire May 15, 2025 and remain in service through June 30, 2025; Christiane Ohlgart is set to become CFO.
For the quarter ended December 31, 2024, e.l.f. Beauty reported net sales up 31% to $355.3 million, but GAAP diluted earnings per share fell to $0.30 from $0.46 a year earlier. The company lowered its fiscal 2025 outlook, with net sales now expected at $1,300-1,310 million versus the prior $1,315-1,335 million, and it cited softer than expected trends in January.
Q3 net sales rose 31% to $355.3 million; GAAP net income was $17.3 million versus $26.9 million a year earlier.
Q3 GAAP diluted EPS was $0.30 versus $0.46; adjusted diluted EPS was $0.74, flat with the prior year.
Fiscal 2025 net sales outlook cut to $1,300-1,310 million from $1,315-1,335 million; adjusted EBITDA outlook cut to $289-293 million from $304-308 million.
CFO Mandy Fields said the company is taking a prudent approach to the final fiscal quarter given softer January trends.
Paylocity reported second-quarter fiscal 2025 results for the three months ended December 31, 2024, with total revenue of $377.0 million, up 16% from a year earlier. GAAP net income was $37.5 million, or $0.66 per diluted share, down from $38.1 million, or $0.67, a year earlier, and the company said it increased its revenue and profitability guidance for fiscal 2025.
Total revenue was $377.0 million, up 16%; recurring and other revenue was $347.7 million, up 17%.
GAAP net income was $37.5 million, or $0.66 per diluted share, versus $38.1 million, or $0.67, a year earlier.
Fiscal 2025 total revenue is now expected at $1.558 billion to $1.568 billion; adjusted EBITDA at $542.0 million to $550.0 million.
Long-term debt of $325.0 million reflects borrowings to fund the Airbase acquisition on October 1, 2024.
Qualys reported fourth-quarter 2024 revenue of $159.2 million, up 10% year over year, with GAAP net income of $44.0 million and GAAP diluted EPS of $1.19 versus $1.08 a year earlier. The company also guided 2025 revenue to $645.0 million to $657.0 million (6% to 8% growth) and non-GAAP diluted EPS to $5.50 to $5.90, below the $6.13 reported for 2024, and said it would increase its share repurchase program by $200 million.
Q4 2024 non-GAAP net income was $59.4 million, or $1.60 per diluted share, versus $1.40 a year earlier.
Full-year 2024 revenue was $607.6 million, up 10%, and GAAP net income was $173.7 million, or $4.65 per diluted share.
2025 guidance: full-year GAAP EPS of $3.62 to $4.02 and non-GAAP EPS of $5.50 to $5.90; Q1 2025 revenue of $155.5 million to $158.5 million.
Share repurchase program increased by $200 million; 2024 repurchases of common stock totaled $139.9 million.
First Bancorp (FBNC) said Adam Currie, previously President of First Bank, becomes CEO of the bank effective February 7, 2025, succeeding Michael G. Mayer, who remains President of the company. The company also authorized a stock repurchase plan of up to $40.0 million of its common stock, which the filing says may be modified or discontinued at any time.
Adam Currie appointed President and CEO of First Bank, effective February 7, 2025
Michael G. Mayer relinquishes bank CEO role and remains President of First Bancorp; release says until early 2026
Board authorized repurchases of up to $40.0 million of common stock; no minimum amount required
Christian Wilson, EVP and Chief Operating Officer, signed a new employment agreement effective February 7, 2025
Expedia Group reported fourth-quarter 2024 revenue of $3.2 billion, up 10% from a year earlier, and gross bookings of $24.4 billion, up 13%. GAAP net income attributable to stockholders more than doubled to $299 million, and the board's Executive Committee declared a $0.40 quarterly dividend, reinstating a payout suspended in 2020 that shareholders will receive if they are on record by March 6, 2025.
Q4 2024 gross bookings were $24.4 billion, up 13%, and booked room nights were 86.4 million, up 12%.
Q4 2024 net income attributable to Expedia Group stockholders was $299 million, versus $132 million; diluted EPS was $2.20, versus $0.92.
Quarterly dividend of $0.40 per share: record date March 6, 2025; payable March 27, 2025.
In 2024, the company repurchased over 12 million shares for $1.6 billion.
Monolithic Power Systems reported fourth-quarter 2024 revenue of $621.7 million, up 36.9% from $454.0 million a year earlier, and non-GAAP diluted earnings of $4.09 per share, up from $2.88. GAAP diluted EPS of $29.88 was inflated by a $1.3 billion tax benefit from a foreign subsidiary. The board raised the quarterly dividend to $1.56 per share from $1.25 and approved a $500 million stock repurchase program that expires February 4, 2028.
Q4 2024 revenue of $621.7 million compared with $454.0 million a year earlier and $620.1 million in the prior quarter.
GAAP net income of $1.4 billion ($29.88 per diluted share) included a $1.3 billion tax benefit; non-GAAP net income was $198.4 million ($4.09 per diluted share).
First-quarter 2025 revenue outlook is $610.0 million to $630.0 million.
Dividend of $1.56 per share payable April 15, 2025 to holders of record as of March 31, 2025.
AGCO reported fourth-quarter and full-year 2024 results on February 6, 2025. Full-year net sales fell 19.1% to $11.7 billion, and reported net loss was $(5.69) per share, compared with net income of $15.63 per share in 2023, after impairment charges, restructuring costs and a $507.3 million loss on the sale of the Grain & Protein business. The company reaffirmed its 2025 outlook of net sales of about $9.6 billion and earnings per share of $4.00 to $4.50, which shareholders will watch as industry demand weakens.
Full-year 2024 adjusted net income was $7.50 per share, versus $15.55 in 2023 (non-GAAP).
Fourth-quarter 2024 net sales were $2.9 billion, down 24.0%, with a reported net loss of $(3.42) per share.
2025 outlook: net sales of about $9.6 billion, adjusted operating margin of about 7% to 7.5%, and earnings per share of $4.00 to $4.50.
Sonos reported first quarter fiscal 2025 revenue of $551 million, down from $613 million a year earlier, and GAAP net income of $50.2 million, down from $80.9 million. The company also disclosed a reorganization and reduction in force affecting about 12% of employees, with expected restructuring charges of $15 million to $18 million, mostly in the second quarter. Shareholders face lower reported profit and a restructuring charge, and the company will provide guidance only on its earnings call.
Revenue of $551 million versus $613 million in the prior-year quarter; Americas revenue was $325 million versus $392 million
GAAP diluted EPS of $0.40 versus $0.64 a year earlier; non-GAAP diluted EPS of $0.64 versus $0.84
Expected restructuring and related charges of $15 million to $18 million, substantially all for employee severance and benefits, mostly in fiscal Q2 2025
No numerical guidance in the release; the company will provide guidance on its first quarter earnings call
Darling Ingredients reported fourth-quarter 2024 net income of $101.9 million, or $0.63 per diluted share, up from $0.52 a year earlier, while net sales fell to $1.4 billion from $1.6 billion and Combined Adjusted EBITDA fell to $289.5 million from $350.9 million. For fiscal 2024, net income fell to $278.9 million from $647.7 million, and the company gave 2025 Combined Adjusted EBITDA guidance of $1.25 to $1.30 billion, compared with $1.08 billion in 2024.
Q4 2024 net income attributable to Darling was $101.9 million, or $0.63 per diluted share, versus $84.5 million, or $0.52, in Q4 2023.
Q4 2024 total net sales were $1.4 billion, down from $1.6 billion, reflecting lower finished product pricing.
Fiscal 2024 net income was $278.9 million, or $1.73 per diluted share, versus $647.7 million, or $3.99, in fiscal 2023.
2025 guidance calls for Combined Adjusted EBITDA of $1.25 to $1.30 billion, versus $1.08 billion for fiscal 2024.
InterDigital reported fourth quarter 2024 revenue of $252.8 million, up from $105.5 million a year earlier, and diluted EPS of $4.09 versus $1.41. Full-year 2024 revenue was $868.5 million, up 58%, and the company raised its quarterly dividend from $0.45 to $0.60 per share, starting with the dividend paid in the second quarter of 2025. The company also gave full-year 2025 revenue guidance of $660 million to $760 million and diluted EPS guidance of $6.79 to $9.67.
Q4 2024 revenue $252.8 million vs. $105.5 million in Q4 2023; diluted EPS $4.09 vs. $1.41
Full-year 2024 revenue $868.5 million, up 58%; diluted EPS $12.07 vs. $7.62
Quarterly dividend increased from $0.45 to $0.60 per share, effective with the dividend paid in Q2 2025
2025 outlook: full-year revenue $660 million to $760 million; Q1 2025 revenue $112 million to $116 million
BorgWarner reported fourth quarter 2024 net sales of $3,439 million, down 2.4%, and a GAAP net loss of $(1.84) per diluted share, driven by $646 million of goodwill and fixed asset impairment charges. The company also gave 2025 guidance for net sales of $13.4 billion to $14.0 billion and GAAP earnings of $3.84 to $4.12 per diluted share, and declared a quarterly dividend of $0.11 per share.
Q4 2024 GAAP net loss of $(1.84) per diluted share, compared with earnings of $0.64 in Q4 2023; adjusted EPS was $1.01 versus $0.90
Full-year 2024 net sales of $14,086 million, down 0.8%; GAAP EPS $1.63 versus $2.70 in 2023
2025 guidance: net sales $13.4 billion to $14.0 billion, adjusted EPS $4.05 to $4.40, free cash flow $650 million to $750 million
Quarterly dividend of $0.11 per share, payable March 17, 2025, to holders of record on March 3, 2025
Ralph Lauren reported fiscal third-quarter 2025 results for the quarter ended December 28, 2024, with revenue up 11% to $2.1 billion and diluted earnings per share of $4.66, up 11% from $4.19 a year earlier. The company raised its full-year fiscal 2025 revenue and adjusted operating margin expansion outlook, which is a positive signal for shareholders.
Q3 diluted EPS was $4.66 reported and $4.82 adjusted, up 11% and 16% respectively from the prior year
Q3 revenue rose 11% to $2.1 billion, with North America up 7%, Europe up 16% and Asia up 14%
Full-year fiscal 2025 constant currency revenue growth is now expected at approximately 6% to 7%
Company repurchased approximately $74 million of Class A common stock in the third quarter
LKQ appointed Sue Gove and Michael Powell to its board effective February 5, 2025, increasing the board from 11 to 13 members, under a cooperation agreement with investors Ancora Catalyst Institutional and Engine Capital. The company also formed a Finance Committee to make recommendations to the board on capital allocation and business portfolio. The filing sets standstill, voting and non-disparagement terms but discloses no financial results or guidance.
Cooperation Agreement dated February 5, 2025 with Ancora Catalyst Institutional, LP and Engine Capital, LP and their affiliates
Board increased from 11 to 13 members; Sue Gove and Michael Powell each have a term expiring at the 2025 annual meeting
Five-member Finance Committee chaired by Andrew Clarke, with Gove, Powell, John Mendel and Xavier Urbain
Investor standstill runs until the earlier of 30 days before the 2026 annual meeting nomination deadline or 110 days before the first anniversary of the 2025 annual meeting
Arrow Electronics reported fourth-quarter 2024 sales of $7.28 billion, down 7% from a year earlier, and GAAP diluted earnings of $1.86 per share, down from $3.54. For full-year 2024, sales fell 16% to $27.9 billion and GAAP diluted EPS was $7.29, versus $15.84 in 2023. The company said fourth-quarter sales and EPS were above the high end of its own guidance ranges and gave first-quarter 2025 guidance of $5.98 billion to $6.58 billion in sales.
Q4 2024 sales were $7.28 billion versus $7.85 billion in Q4 2023; GAAP diluted EPS was $1.86 versus $3.54, and non-GAAP EPS was $2.97 versus $3.98.
Full-year 2024 sales were $27.9 billion, down 16%, and GAAP diluted EPS was $7.29 versus $15.84 in 2023.
Q1 2025 outlook: consolidated sales of $5.98 billion to $6.58 billion and GAAP diluted EPS of $0.98 to $1.18.
The company said Q4 sales and EPS were above the high end of its guidance ranges.
Under Armour reported third-quarter fiscal 2025 revenue down 6% to $1.4 billion, with net income of $1 million compared with $111 million a year earlier. The company raised its adjusted diluted EPS outlook to $0.28 to $0.30 from $0.24 to $0.27, while still expecting revenue to fall about 10% for the year, which matters to shareholders because results and guidance point in different directions.
Q3 revenue fell 6% to $1.4 billion; North America fell 8% to $844 million.
Q3 GAAP net income was $1 million; adjusted net income was $35 million; adjusted diluted EPS was $0.08.
Fiscal 2025 adjusted diluted EPS outlook raised to $0.28 to $0.30 from $0.24 to $0.27; GAAP diluted loss per share expected at $0.48 to $0.50.
Restructuring plan range increased to $140 million to $160 million; company had $727 million in cash at quarter end.
Maximus reported fiscal first-quarter 2025 revenue of $1.40 billion, up 5.7% from a year earlier, and raised its full-year fiscal 2025 adjusted diluted EPS guidance to $5.90 to $6.20. GAAP diluted EPS fell to $0.69 from $1.04 because of about $38 million in divestiture-related charges, which shareholders will weigh against the higher adjusted results and guidance.
Revenue rose 5.7% to $1.40 billion; U.S. Federal Services revenue rose 15.3% to $780.7 million.
Diluted EPS was $0.69 versus $1.04 a year earlier; adjusted diluted EPS was $1.61 versus $1.34.
Full-year fiscal 2025 revenue guidance is $5.2 billion to $5.35 billion, and free cash flow guidance is $355 million to $385 million.
Q1 cash used in operating activities was $80.0 million; the company bought back 3.1 million shares for $237 million in the quarter.
HII reported fourth-quarter 2024 revenue of $3.0 billion and diluted earnings per share of $3.15, down from $3.2 billion and $6.90 a year earlier. The company said lower volume, weaker performance at Newport News Shipbuilding, and prior-year gains from a court judgment sale and an insurance settlement drove the decline. The release also gave 2025 outlook, including free cash flow of $300 million to $500 million, and year-end backlog of $48.7 billion.
Q4 2024 revenue was $3.0 billion, compared with $3.2 billion in Q4 2023; segment operating margin was 3.4%, versus 10.4%
Q4 2024 diluted EPS was $3.15, compared with $6.90 in Q4 2023; full-year 2024 diluted EPS was $13.96, versus $17.07
Full-year 2024 revenue was $11.5 billion, up less than 1%; net cash from operating activities was $393 million
FY25 outlook includes free cash flow of $300 million to $500 million; backlog was $48.7 billion as of December 31, 2024
Peloton reported fiscal Q2 2025 results for the quarter ended December 31, 2024, with total revenue of $673.9 million, down 9% year over year but $13.9 million above the high end of its $640 million to $660 million guidance range. The company raised its full-year fiscal 2025 Adjusted EBITDA guidance to $300 million to $350 million from $240 million to $290 million and its Free Cash Flow target to at least $200 million from $125 million.
Q2 total revenue was $673.9 million, down 9% year over year, and above the $640 million to $660 million guidance range.
Net loss was $92.0 million, an improvement of $102.9 million year over year; Adjusted EBITDA was $58.4 million.
Free Cash Flow was $106.0 million in Q2, and cash and cash equivalents ended the quarter at $829.0 million.
FY25 Adjusted EBITDA guidance was raised to $300 million to $350 million from $240 million to $290 million; Free Cash Flow target was raised to at least $200 million from $125 million.
Tapestry reported fiscal second-quarter 2025 net sales of $2.20 billion, up 5% from a year earlier, with non-GAAP diluted EPS of $2.00 versus $1.63 a year earlier. Reported diluted EPS was $1.38, slightly below $1.39 a year earlier, after a $120 million loss on debt extinguishment tied to the terminated Capri Holdings merger. The company raised its fiscal 2025 non-GAAP EPS outlook to $4.85 to $4.90 from $4.50 to $4.55, and expects to return more than $2 billion to shareholders this fiscal year.
Q2 net sales of $2.20 billion, up 5%; Coach sales rose 11% on a reported basis.
Non-GAAP diluted EPS of $2.00 versus $1.63 a year earlier; reported diluted EPS of $1.38 versus $1.39.
Fiscal 2025 non-GAAP EPS outlook raised to $4.85 to $4.90 from $4.50 to $4.55.
Reported net income of $310 million, including a $120 million loss on debt extinguishment tied to the terminated Capri Holdings merger.
CMS Energy reported full-year 2024 diluted EPS of $3.33, up from $3.01, and adjusted EPS of $3.34, up from $3.11. It raised its 2025 adjusted EPS guidance to $3.54 to $3.60 from $3.52 to $3.58 and increased its annual dividend by 11 cents to $2.17 per share. Fourth-quarter results were lower than a year earlier, with diluted EPS of $0.87 compared with $1.05.
Full-year 2024 operating revenue was $7.5 billion ($7,515 million) versus $7.5 billion ($7,462 million) in 2023, and net income available to common stockholders was $993 million versus $877 million.
Fourth-quarter 2024 net income available to common stockholders was $262 million, down from $306 million in the fourth quarter of 2023.
2025 adjusted EPS guidance was raised to $3.54 to $3.60 from $3.52 to $3.58 per share, and long-term adjusted EPS growth of 6 to 8 percent was reaffirmed.
The company's 2025 annual dividend is $2.17 per share, up 11 cents, its 19th consecutive annual increase.
Haemonetics reported third-quarter fiscal 2025 revenue of $348.5 million, up 3.7%, and GAAP earnings of $0.74 per diluted share, up from $0.61. The company lowered its fiscal 2025 reported revenue growth guidance to 3% to 5% from 5% to 8% and cut free cash flow guidance to $120 million to $140 million from $130 million to $180 million, while narrowing its adjusted earnings per share guidance to $4.50 to $4.70.
Third-quarter revenue was $348.5 million, up 3.7%, while organic revenue decreased 0.3%.
GAAP earnings per diluted share were $0.74, versus $0.61 a year earlier; adjusted earnings per diluted share were $1.19, up 14.4%.
Fiscal 2025 reported revenue growth guidance was lowered to 3% to 5% from 5% to 8%.
Free cash flow guidance was cut to $120 million to $140 million from $130 million to $180 million; adjusted earnings per share guidance was narrowed to $4.50 to $4.70 from $4.45 to $4.75.
Prestige Consumer Healthcare reported third-quarter fiscal 2025 revenue of $290.3 million, up 2.7%, with diluted EPS of $1.22 versus $1.06 a year earlier. The company raised its fiscal 2025 adjusted diluted EPS outlook to approximately $4.50 from $4.40 to $4.46, and narrowed its revenue outlook to $1,128 million to $1,132 million. Nine-month revenue declined 0.8%, and third-quarter free cash flow fell, so shareholders gain from higher earnings guidance but see mixed trends in sales and cash flow.
Q3 revenue $290.3 million, up 2.7% from $282.7 million; diluted EPS $1.22 versus $1.06
Nine-month revenue $841.2 million, down 0.8%; non-GAAP adjusted diluted EPS $3.20 versus $3.19
FY2025 adjusted diluted EPS outlook raised to approximately $4.50 from $4.40 to $4.46; revenue outlook $1,128 million to $1,132 million
Q3 non-GAAP free cash flow $63.5 million versus $69.5 million; net debt about $0.9 billion, leverage 2.5x
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.